Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A high-throughput nonisotopic protein truncation test.

Sadanand Gite1, Mark Lim, Rick Carlson

  • 1AmberGen, Inc., 1106 Commonwealth Avenue, Boston, MA 02215, USA. sadanand@ambergen.com

Nature Biotechnology
|January 14, 2003
PubMed
Summary

A new high-throughput protein truncation test (HTS-PTT) simplifies detecting chain-truncating mutations in disease genes like APC. This method enables faster, more accurate genetic analysis for cancer screening and diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes and Challenges in Molecular Diagnostics.

The Journal of molecular diagnostics : JMD·2024
Same author

Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.

Clinical journal of the American Society of Nephrology : CJASN·2024
Same author

Evaluation of antibody-based single cell type imaging techniques coupled to multiplexed imaging of N-glycans and collagen peptides by matrix-assisted laser desorption/ionization mass spectrometry imaging.

Analytical and bioanalytical chemistry·2023
Same author

Post-COVID-19 syndrome risk factors and further use of health services in East England.

PLOS global public health·2023
Same author

Diagnostics in the Time of Coronavirus Disease 2019 (COVID-19): Challenges and Opportunities.

The Journal of molecular diagnostics : JMD·2020
Same author

A diver's dilemma - a case report on bronchopulmonary sequestration.

BMC pulmonary medicine·2020

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Chain-truncating mutations (nonsense or frameshift) are common in disease-related genes such as APC, BRCA1/2, PKD1, NF1/2, and DMD.
  • The conventional protein truncation test (PTT) detects these mutations but is difficult to scale for high-throughput applications due to reliance on SDS-PAGE and manual analysis.
  • Limitations of conventional PTT include susceptibility to human error and challenges in adapting to automated, large-scale screening.

Purpose of the Study:

  • To develop a high-throughput, automated method for detecting chain-truncating mutations.
  • To overcome the limitations of conventional PTT, including its low throughput and susceptibility to human error.
  • To enable efficient genetic screening for diseases like colorectal cancer and familial adenomatous polyposis.

Related Experiment Videos

Main Methods:

  • Developed a high-throughput solid-phase protein truncation test (HTS-PTT) utilizing misaminoacylated tRNAs with affinity tags for protein capture.
  • Incorporated N- and C-terminal markers via specialized PCR primers to quantify shortened polypeptide fragments.
  • Employed a 96-well microtiter plate ELISA format with chemiluminescence detection for single-well capture and analysis of cell-free expressed protein fragments.

Main Results:

  • Successfully demonstrated HTS-PTT for detecting chain-truncation mutations in the APC gene.
  • Validated the technique using DNA and RNA from cancer cell lines and DNA from individuals with familial adenomatous polyposis.
  • Showcased the potential of HTS-PTT for high-throughput, noninvasive colorectal cancer screening when combined with DNA enrichment and amplification methods.

Conclusions:

  • HTS-PTT offers a robust, high-throughput alternative to conventional PTT for detecting chain-truncating mutations.
  • The developed method streamlines genetic analysis, reducing human error and enabling large-scale screening.
  • HTS-PTT holds significant promise for applications in disease diagnosis, genetic screening, and cancer research.